Brown Shoe Co., Inc. (BWS) Tops Q4 EPS by 4c; Guides Fy14
Tweet
Share
E-mailGet Alerts BWS Hot Sheet
Price: $31.67 --0%
Financial Fact:
Net (loss) earnings attributable to Brown Shoe Company, Inc.: 34.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net (loss) earnings attributable to Brown Shoe Company, Inc.: 34.73M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Brown Shoe Co., Inc. (NYSE: BWS) reported Q4 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $600 million versus the consensus estimate of $621.15 million.
Famous Footwear fourth quarter 2013 sales of $347.4 million were down 8.6% year-over-year, with same-store-sales(1) down 1.8%. Performance in the quarter was impacted by severe winter weather, which hurt running shoe sales while helping to drive boot sales. During the quarter, 13 stores were closed or relocated and nine new stores were added.
Sees FY2014 EPS of $1.45-$1.55, versus the consensus of $1.61. Also sees FY2014 revenue of $2.58-2.60 billion, versus the consensus of $2.61 billion. Expects comps up in low-single-digit range.
For earnings history and earnings-related data on Brown Shoe Co., Inc. (BWS) click here.
Famous Footwear fourth quarter 2013 sales of $347.4 million were down 8.6% year-over-year, with same-store-sales(1) down 1.8%. Performance in the quarter was impacted by severe winter weather, which hurt running shoe sales while helping to drive boot sales. During the quarter, 13 stores were closed or relocated and nine new stores were added.
Sees FY2014 EPS of $1.45-$1.55, versus the consensus of $1.61. Also sees FY2014 revenue of $2.58-2.60 billion, versus the consensus of $2.61 billion. Expects comps up in low-single-digit range.
For earnings history and earnings-related data on Brown Shoe Co., Inc. (BWS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Vivos Therapeutics posts 35% revenue gain but widens net loss
Create E-mail Alert Related Categories
Earnings, Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
